The concept of innovative drugs fluctuates and rebounds, ClinPlus rises over 10%
The concept of innovative drugs fluctuated and rebounded during the day, with the CXO sector leading the gains. ClinPlus rose over 10%, while Medicilon, JZT, Thalys, HUIYU PHARMACEUTICAL, and Shanghai Yizhong all rose over 6%
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments